Jessica A Alvarez
Overview
Explore the profile of Jessica A Alvarez including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
104
Citations
1582
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Yu M, Gerig L, Mehta C, Musonge-Effoe J, Alvarez J, Ofotokun I, et al.
Clin Infect Dis
. 2025 Feb;
PMID: 39899358
Background: The impact of integrase strand-transfer inhibitors (INSTIs) on steatotic liver disease in women with HIV (WWH) is unknown. Methods: Using data collected in the Women's Interagency HIV Study from...
2.
Tripathi A, Dabeer S, Song J, Vikulina T, Roser-Page S, Alvarez J, et al.
Cell Death Dis
. 2024 Dec;
15(12):907.
PMID: 39695103
Sickle cell disease (SCD) is a severe hematological disorder characterized by erythrocyte sickling that causes significant morbidity and mortality. Skeletal complications of SCD include a high incidence of bone loss,...
3.
Cousineau B, Mitchell E, Hodge R, Vaccarino V, Alvarez J, Flanders W, et al.
J Nutr
. 2024 Nov;
155(2):580-588.
PMID: 39603534
Background: The Overall Plant-based Diet Index (PDI), the Healthful Plant-based Diet Index (hPDI), and the Unhealthful Plant-based Diet Index (uPDI) are relatively new tools for characterizing the quality of plant-based...
4.
Plaisance E, Bergeron J, Bolyard M, Hathorne H, Graziano C, Hartzes A, et al.
Nutrients
. 2024 Nov;
16(22).
PMID: 39599743
Introduction: Cystic fibrosis transmembrane conductance regulator () modulators have greatly improved outcomes in persons with CF (pwCF); however, there is still significant heterogeneity in clinical responses, particularly with regard to...
5.
Alvarez J, Yang C, Ojuri V, Buckley K, Bedi B, Musonge-Effoe J, et al.
Curr HIV/AIDS Rep
. 2024 Nov;
22(1):3.
PMID: 39570329
Purpose Of Review: As advances in antiretroviral therapy for people with HIV (PWH) have prolonged lifespans, prevalence of aging and obesity related metabolic disorders have increased. The purpose of this...
6.
Lahiri C, Mehta C, Yang Q, Maramba T, Musonge-Effoe J, Yang C, et al.
Clin Infect Dis
. 2024 Sep;
PMID: 39324701
Background: Sex-specific, long-term, body weight change in persons with HIV (PWH) following switch to regimens containing integrase strand-transfer inhibitors (INSTIs) is unknown. Methods: We compared PWH enrolled in the MACS/WIHS...
7.
Suppakitjanusant P, Wang Y, Sivapiromrat A, Hu C, Binongo J, Hunt W, et al.
J Clin Transl Endocrinol
. 2024 Aug;
37:100362.
PMID: 39188269
Background: Cystic fibrosis (CF) is a multi-organ disease caused by mutations in the cystic fibrosis transmembrane conductance regulator (CFTR). Individuals with CF often have gastrointestinal (GI) dysbiosis due to chronic...
8.
Bass R, Alvarez J
Pediatr Pulmonol
. 2024 Aug;
59 Suppl 1:S6-S16.
PMID: 39105341
Advances in cystic fibrosis (CF) diagnostics and therapeutics have led to improved health and longevity, including increased body weight and decreased malnutrition in people with CF. Highly effective CFTR modulator...
9.
Gundogan K, Nellis M, Ozer N, Ergul S, Sahin G, Temel S, et al.
Metabolomics
. 2024 Jul;
20(4):83.
PMID: 39066851
Introduction: Thiamine (Vitamin B1) is an essential micronutrient and is classically considered a co-factor in energy metabolism. The association between thiamine status and whole-body metabolism in critical illness has not...
10.
Van Citters A, Aliaj E, Alvarez J, Brown C, Cary J, Cravens R, et al.
J Cyst Fibros
. 2024 Jul;
PMID: 39060182
Background: People with cystic fibrosis (PwCF) have experienced substantial improvements in health following use of cystic fibrosis transmembrane conductance regulator (CFTR) modulator therapies. However, less is known about how modulator...